199 related articles for article (PubMed ID: 28757391)
21. Neural Mobilization Attenuates Mechanical Allodynia and Decreases Proinflammatory Cytokine Concentrations in Rats With Painful Diabetic Neuropathy.
Zhu GC; Tsai KL; Chen YW; Hung CH
Phys Ther; 2018 Apr; 98(4):214-222. PubMed ID: 29309710
[TBL] [Abstract][Full Text] [Related]
22. Peripheral pain is enhanced by insulin-like growth factor 1 and its receptors in a mouse model of type 2 diabetes mellitus.
Tang Z; Cao F; Zhang H; Tang J; Li H; Zhang Y; Feng B; Wang H
J Diabetes; 2019 Apr; 11(4):309-315. PubMed ID: 30105862
[TBL] [Abstract][Full Text] [Related]
23. CX3CR1 contributes to streptozotocin-induced mechanical allodynia in the mouse spinal cord.
Ni CM; Ling BY; Xu X; Sun HP; Jin H; Zhang YQ; Cao H; Xu L
J Zhejiang Univ Sci B; 2020 Feb.; 21(2):166-171. PubMed ID: 32115913
[TBL] [Abstract][Full Text] [Related]
24. High-mobility group box 1 contributes to mechanical allodynia and spinal astrocytic activation in a mouse model of type 2 diabetes.
Ren PC; Zhang Y; Zhang XD; An LJ; Lv HG; He J; Gao CJ; Sun XD
Brain Res Bull; 2012 Jul; 88(4):332-7. PubMed ID: 22459482
[TBL] [Abstract][Full Text] [Related]
25. Pre-emptive analgesia and its supraspinal mechanisms: enhanced descending inhibition and decreased descending facilitation by dexmedetomidine.
You HJ; Lei J; Xiao Y; Ye G; Sun ZH; Yang L; Niu N
J Physiol; 2016 Apr; 594(7):1875-90. PubMed ID: 26732231
[TBL] [Abstract][Full Text] [Related]
26. Lidocaine attenuates the development of diabetic-induced tactile allodynia by inhibiting microglial activation.
Suzuki N; Hasegawa-Moriyama M; Takahashi Y; Kamikubo Y; Sakurai T; Inada E
Anesth Analg; 2011 Oct; 113(4):941-6. PubMed ID: 21788310
[TBL] [Abstract][Full Text] [Related]
27. Effects of heme oxygenase 1 in the molecular changes and neuropathy associated with type 2 diabetes in mice.
Pouso-Vázquez E; Bai X; Batallé G; Roch G; Pol O
Biochem Pharmacol; 2022 May; 199():114987. PubMed ID: 35276215
[TBL] [Abstract][Full Text] [Related]
28. Impaired noradrenaline homeostasis in rats with painful diabetic neuropathy as a target of duloxetine analgesia.
Kinoshita J; Takahashi Y; Watabe AM; Utsunomiya K; Kato F
Mol Pain; 2013 Nov; 9():59. PubMed ID: 24279796
[TBL] [Abstract][Full Text] [Related]
29. The antiallodynic action of nortriptyline and terbutaline is mediated by β(2) adrenoceptors and δ opioid receptors in the ob/ob model of diabetic polyneuropathy.
Choucair-Jaafar N; Salvat E; Freund-Mercier MJ; Barrot M
Brain Res; 2014 Feb; 1546():18-26. PubMed ID: 24361988
[TBL] [Abstract][Full Text] [Related]
30. Contribution of α2A-adrenoceptor subtype to effect of dexmedetomidine and xylazine on spinal synaptic transmission of mice.
Kobayashi T; Otsuguro K; Yamaguchi S; Ito S
Eur J Pharmacol; 2015 Aug; 761():321-9. PubMed ID: 26086861
[TBL] [Abstract][Full Text] [Related]
31. miR-125a-5p in astrocytes attenuates peripheral neuropathy in type 2 diabetic mice through targeting TRAF6.
Kasimu A; Apizi X; Talifujiang D; Ma X; Fang L; Zhou X
Endocrinol Diabetes Nutr (Engl Ed); 2022 Jan; 69(1):43-51. PubMed ID: 35232559
[TBL] [Abstract][Full Text] [Related]
32. Dexmedetomidine increases hippocampal phosphorylated extracellular signal-regulated protein kinase 1 and 2 content by an alpha 2-adrenoceptor-independent mechanism: evidence for the involvement of imidazoline I1 receptors.
Dahmani S; Paris A; Jannier V; Hein L; Rouelle D; Scholz J; Gressens P; Mantz J
Anesthesiology; 2008 Mar; 108(3):457-66. PubMed ID: 18292683
[TBL] [Abstract][Full Text] [Related]
33. Involvement of spinal microglia and interleukin-18 in the anti-nociceptive effect of dexmedetomidine in rats subjected to CCI.
Li SS; Zhang WS; Ji D; Zhou YL; Li H; Yang JL; Xiong YC; Zhang YQ; Xu H
Neurosci Lett; 2014 Feb; 560():21-5. PubMed ID: 24345418
[TBL] [Abstract][Full Text] [Related]
34. Dexmedetomidine Protects Rat Liver against Ischemia-Reperfusion Injury Partly by the α2A-Adrenoceptor Subtype and the Mechanism Is Associated with the TLR4/NF-κB Pathway.
Wang Y; Wu S; Yu X; Zhou S; Ge M; Chi X; Cai J
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347929
[TBL] [Abstract][Full Text] [Related]
35. Down-regulation of insulin signaling is involved in painful diabetic neuropathy in type 2 diabetes.
Kou ZZ; Li CY; Tang J; Hu JC; Qu J; Liao YH; Wu SX; Li H; Li YQ
Pain Physician; 2013; 16(2):E71-83. PubMed ID: 23511693
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effect of glutamate release from rat cerebrocortical nerve terminals by α2 adrenoceptor agonist dexmedetomidine.
Chiu KM; Lin TY; Lu CW; Wang SJ
Eur J Pharmacol; 2011 Nov; 670(1):137-47. PubMed ID: 21914443
[TBL] [Abstract][Full Text] [Related]
37. Effect of subacute agomelatine treatment on painful diabetic neuropathy: involvement of catecholaminergic mechanisms.
Aydın TH; Can ÖD; Demir Özkay Ü; Turan N
Fundam Clin Pharmacol; 2016 Dec; 30(6):549-567. PubMed ID: 27421789
[TBL] [Abstract][Full Text] [Related]
38. Inhibition by dexmedetomidine of the activation of spinal dorsal horn glias and the intracellular ERK signaling pathway induced by nerve injury.
Liu L; Ji F; Liang J; He H; Fu Y; Cao M
Brain Res; 2012 Jan; 1427():1-9. PubMed ID: 22050961
[TBL] [Abstract][Full Text] [Related]
39. Dexmedetomidine alleviates rat post-ischemia induced allodynia through GRK2 upregulation in superior cervical ganglia.
Dong J; Yang L; Tang J; Zheng J
Auton Neurosci; 2015 Jan; 187():76-83. PubMed ID: 25466829
[TBL] [Abstract][Full Text] [Related]
40. Neuroprotective and antihyperalgesic effects of orexin-A in rats with painful diabetic neuropathy.
Niknia S; Kaeidi A; Hajizadeh MR; Mirzaei MR; Khoshdel A; Hajializadeh Z; Fahmidehkar MA; Mahmoodi M
Neuropeptides; 2019 Feb; 73():34-40. PubMed ID: 30447858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
